Is Avandia Worth The Risk?

Share

Is Avandia Worth The Risk?

There has been several reported deaths from Avandia from heart attacks and strokes but meanwhile the FDA has refused to recall it. they have only recently updated their warnings about the increased risks to patients. While there are alternates to using Avandia why takeĀ  the risks?

Avandia manufactured by GlaxoSmithKline was approved on May 25, 1999 after a 6 month fast track approval. It was approved for the control of blood sugars in type 2 diabetes patients. Sale of the drug climbed earning more than $1.5 billion in the year 2004 alone.

Dr. Nissen studied the side effects and risk of Avandia and concluded in 2007 that Avandia had increased the risks of heart attacks. Studies have estimated that over 47,000 people have suffered a heart attack, stroke, or heart failure, or died from 1999 to 2009 before the drug was banned from Europe and severely limited for sale to patients in the USA. The Us Senate would eventually undertake an investigation into Avandia. The results were that they found GlaxoSmithKline had intentionally hid the results of the clinical trials from the FDA.

The official statement from the FDIC “On September 23, 2010, FDA announced that it would significantly restrict the use of rosiglitazone-containing medicines to patients with Type 2 diabetes who cannot control their blood sugar on other medicines. These new restrictions were in response to data that suggested an elevated risk of heart attacks in patients treated with Avandia(rosiglitazone).”

Share
This entry was posted in Avandia, Endocrinology, FDA 2011, FDA Warning and tagged , , , , , , , , , , , , , , . Bookmark the permalink.